JOURNAL OF BIOMEDICAL SCIENCE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2025-03-19 ms6000001202199158 来自上海

审稿速度:1.0 | 投稿命中率:25.0
经验分享：2025年2月27日——投稿
2025年2月28日——转editor处理
2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2018-04-21 哼哈二将

请问可以撤稿吗?投了一个月没有消息啊

419 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2025-01-13 ms9000000416465180 来自广东省

偏重的研究方向：癌症生物学
经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2025-01-04 ms2000001438324149 来自天津

请问需要上传所有原始数据吗？

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2022-08-13 124d2c45m98暂无昵称

edditor assigned 15天了，大家一般都多久啊？

0 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2024-11-11 ms6000000294853759 来自广东省

请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗

35 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2024-12-30 Anghuhao 来自湖南省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。

24 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2024-10-29 turing 来自新加坡

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：信号通路;干细胞;巨噬细胞
经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2024-08-21 ms9000001819006819 来自广东省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：无

120 0

[GetPortalCommentsPageByObjectIdResponse(id=2256708, encodeId=a1922256e0867, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：2025年2月27日——投稿 2025年2月28日——转editor处理 2025年3月17日——收到拒稿邮件，并通知只有3%的稿件会送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fee5473308, createdName=ms6000001202199158, createdTime=Wed Mar 19 09:35:42 CST 2025, time=2025-03-19, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=555236, encodeId=908a555236bd, content=请问可以撤稿吗?投了一个月没有消息啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200530/d80283577c4e449e95aa9c62ad93c96b/6e143c00ca7742b9bbb70de47158bfd4.jpg, createdBy=95c41731260, createdName=哼哈二将, createdTime=Sat Apr 21 17:07:00 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247843, encodeId=d03f224e843eb, content=偏重的研究方向：癌症生物学 经验分享：之前接收了一篇Research，速度偏中，提交到送审大概3周，审稿四五周，所以每轮两个月左右会返回结果。编辑比较负责，任何小问题都重新送审，所以我的经历了4轮审稿。2024年发文105，投稿量6000+，中稿率偏低，想快速水文的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Mon Jan 13 10:49:21 CST 2025, time=2025-01-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2246587, encodeId=da3b224658eb3, content=请问需要上传所有原始数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19a35639370, createdName=ms2000001438324149, createdTime=Sat Jan 04 22:59:19 CST 2025, time=2025-01-04, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1238504, encodeId=2016123850460, content=edditor assigned 15天了，大家一般都多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=775a2517960, createdName=124d2c45m98暂无昵称, createdTime=Sat Aug 13 17:28:31 CST 2022, time=2022-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2236365, encodeId=72f2223636577, content=请问期刊系统里仍显示editor assigned 但在springer nature的投稿系统里看到这篇文章显示under review是已经送外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b72f6540330, createdName=ms6000000294853759, createdTime=Mon Nov 11 18:33:17 CST 2024, time=2024-11-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245606, encodeId=d47422456069b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：12.11提交，12.13开始editor assigned，12.30编辑拒稿，并附接收率低于3%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=Anghuhao, createdTime=Mon Dec 30 14:46:39 CST 2024, time=2024-12-30, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233854, encodeId=51ed223385450, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：信号通路;干细胞;巨噬细胞 经验分享：投稿两周直接拒稿，邮件说外审概率是8%，这个期刊影响因子上来了，难度增加了。性价比很一般，建议综述可以投一下，article还是找其他杂志比较好。24-8-20日投稿，稿件号2995。 24-10-18号投稿。稿件号4752。今年发了100篇文章，也就是接收率低于2.1%。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bde21652712, createdName=turing, createdTime=Tue Oct 29 10:54:23 CST 2024, time=2024-10-29, status=1, ipAttribution=新加坡), GetPortalCommentsPageByObjectIdResponse(id=2221624, encodeId=0b792221624c1, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd9b9309049, createdName=ms9000001819006819, createdTime=Wed Aug 21 01:18:13 CST 2024, time=2024-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2221253, encodeId=fc642221253f2, content=偏重的研究方向：肿瘤药理 经验分享：急的慎投，十几天了还卡在editor assigned, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2035326675, createdName=whal, createdTime=Mon Aug 19 09:59:12 CST 2024, time=2024-08-19, status=1, ipAttribution=江苏省)]

2024-08-19 whal 来自江苏省

偏重的研究方向：肿瘤药理
经验分享：急的慎投，十几天了还卡在editor assigned

120 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务